alosetron and dicyclomine

alosetron has been researched along with dicyclomine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Mearin, F	1

Reviews

2 review(s) available for alosetron and dicyclomine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Drug treatment of irritable bowel syndrome: an unmet need]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3 Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine	2007

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

[Drug treatment of irritable bowel syndrome: an unmet need].

Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3

Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine

2007